Ischemia, heart failure, fibrosis:
InhibirelA® has a stimulating effect on blood circulation and metabolism, thus helping blood flow.
InhibirelA® can prevent heart damage due to ischemia.
InhibirelA® may inhibit the development of myocardial hypertrophy (enlargement of morbid cardiac muscle developing as a complication of stenosis of the aortic valve or due to treatment with cardiotoxic drugs, eg. Doxorubicin).
InhibirelA® can even improve the myocardial infarction. InhibirelA® inhibits the processes of inflammation and fibrosis (replacement of muscle connective tissue) and prevents the development and deepening of heart failure.
Thrombosis:
InhibirelA® is acting vasodilating and antiplatelet and is a valuable dietary supplement for people at risk for developing cardiovascular disease and patients developing thrombosis, without exerting adverse effects on health.